Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 1:17 PM
Ignite Modification Date:
2025-12-26 @ 1:17 PM
NCT ID:
NCT00601406
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Patients must have received curative external-beam radiotherapy within the context of a formal clinical study for any of the following:
* Early breast cancer after breast-conserving surgery
* Localized prostate cancer
* Gynecological cancer (may have also received brachytherapy)
* Venous blood samples must be available
* Patients will be identified from the following clinical studies:
* Cambridge intensity-modulated radiotherapy breast randomized trial
* RT01 prostate radiotherapy randomized trial/other prostate trials
* Christie hospital breast, prostate, and gynecological cancer radiotherapy patients
* Must have minimum follow up with late normal tissue effect scoring for two years available
PATIENT CHARACTERISTICS:
* No other malignancy prior to treatment for the specified tumor types except basal cell or squamous cell carcinoma of the skin or in situ carcinoma
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00601406
Study Brief:
Protocol Section:
NCT00601406